Skip to content
PHARMACEUTICALS AND DRUG DEVELOPMENT

New mRNA Flu Shot In US Offers Nearly 30% More Protection For Adults 50+

A new flu vaccine has been approved in the US for adults 50+, bringing mRNA technology into seasonal flu prevention and raising questions about whether it offers stronger protection.
USOHIOUNITED STATESJOHNS HOPKINS UNIVERSITYUNIVERSITY OF CALIFORNIA LAW SAN FRANCISCOMODERNA
NBC ConnecticutNBC BostonNBC NewsTelemundo Washington DC (44)TimesNow
20 articles

Coverage

20 articles
Healthcare and Health IT News | Healthcare DiveAug 6TimesNowSep 29

Related